Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation. - Wikidata - awgldk - TriplyDB

Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation.

Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation.

http://www.wikidata.org/entity/Q38435600

about

Cardiovascular gene therapy for myocardial infarction Novel methods of automated quantification of gap junction distribution and interstitial collagen quantity from animal and human atrial tissue sections.Connexin 43 a check-point component of cell proliferation implicated in a wide range of human testis diseases.Fractionation of electrograms is caused by colocalized conduction block and connexin disorganization in the absence of fibrosis as AF becomes persistent in the goat model.Downregulation of connexin43 by microRNA-130a in cardiomyocytes results in cardiac arrhythmias.Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013.In silico assessment of genetic variation in KCNA5 reveals multiple mechanisms of human atrial arrhythmogenesis The Use of Gene Therapy for Ablation of Atrial Fibrillation.Recent insights into the role of the autonomic nervous system in the creation of substrate for atrial fibrillation: implications for therapies targeting the atrial autonomic nervous system.Biological Therapies for Atrial Fibrillation: Ready for Prime Time?Mechanistic inquiry into the role of tissue remodeling in fibrotic lesions in human atrial fibrillation.Wenxin Keli suppresses atrial substrate remodelling after epicardial ganglionic plexi ablation.Human Organotypic Cultured Cardiac Slices: New Platform For High Throughput Preclinical Human Trials.Cross-talk between macrophages and atrial myocytes in atrial fibrillation Gene therapy to treat cardiovascular disease.Expression of connexin 43, ion channels and Ca2+-handling proteins in rat pulmonary vein cardiomyocytes.Atrial fibrillation: mechanisms, therapeutics, and future directions.Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins.Loss of proteostatic control as a substrate for atrial fibrillation: a novel target for upstream therapy by heat shock proteins New directions in antiarrhythmic drug therapy for atrial fibrillation.Cardiac to cancer: connecting connexins to clinical opportunity.Atrial fibrillation-linked GJA5/connexin40 mutants impaired gap junctions via different mechanisms.Diabetes mellitus and atrial remodeling: mechanisms and potential upstream therapies.Atrial fibrillation and heart failure: cause or effect?Mechanisms linking connexin mutations to human diseases.MicroRNAs and atrial fibrillation: mechanisms and translational potential.Gene therapy to restore electrophysiological function in heart failure.Gene therapy to treat cardiac arrhythmias.Serine/Threonine Phosphatases in Atrial Fibrillation.Connexin Remodeling Contributes to Atrial Fibrillation.Ischemic Conditioning and Atrial Fibrillation: Hope for a NewTherapy?Ventricular fibrillation: triggers, mechanisms and therapies.Improving Atrial Fibrillation Therapy: Is There a Gene for That?Genotype influence in responses to therapy for atrial fibrillation.Demystifying rotors and their place in clinical translation of atrial fibrillation mechanisms.Gene Therapy for Atrial Fibrillation in Heart Failure.Current state of the art for cardiac arrhythmia gene therapy.Constitutive Expression of a Dominant-Negative TGF-β Type II Receptor in the Posterior Left Atrium Leads to Beneficial Remodeling of Atrial Fibrillation Substrate.Gene Therapy for Cardiac Arrhythmias.Phosphorylation at Connexin43 Serine-368 Is Necessary for Myocardial Conduction During Metabolic Stress.

P2860

Q27014770-B6422DB2-03F3-4D77-A8C8-11E3224CB047 Q34020522-FC1858EC-661B-45F0-8CC7-2D456C99D705 Q34295662-9D95B5FB-FD78-4F78-9CA3-A6BC3100EEC7 Q35044963-3E85B8D7-89BE-407E-8271-9AC0FEADA13B Q35546522-A5AAB855-94E3-43C1-BA03-D1C2454D6593 Q35585789-A61B00AA-C63C-4E94-A75A-7502707CBA50 Q36407327-F42D67F5-DB1D-48D5-90EC-1E2FDB7923E4 Q36458906-1519C8DE-9F63-4246-8697-20D87F33D69C Q36713691-8BD49BD1-516F-4082-AA9C-53B48E2AB10E Q36934761-CE3F7483-8964-4CFD-BD7C-A206557060F1 Q36939738-F46DE73D-2AD5-4799-B910-1256CC94997A Q37033160-690B40B6-4A0C-4E39-BCFA-1F6D2E0F4547 Q37054318-2250178B-C71D-4519-9568-2289264627DC Q37277429-5F1C8064-EC34-4763-9CA8-360143B2FB6C Q37310450-1B386F4C-404D-40AC-B38B-F5CCC2E4010D Q37406549-F9939B15-7D8F-4007-B6F6-FBB6E4C4531E Q37590158-F25B696E-6B6A-4CDF-88CA-6FE1EFA70901 Q37602866-8DA96640-52FC-4E03-BE9C-FF817A0C077A Q37989142-2A148513-51C7-4AD7-B0E8-3662EB7E3ED7 Q38069201-F056E2E7-1A3D-4F29-9E4C-A3198092E4EB Q38194340-65E65711-A3BF-46A7-9E34-CDED3F9BF4C6 Q38198336-0165FEBC-5C69-46C4-906F-E302EE72AE1F Q38234313-26F627D9-2C59-4890-83BE-C17F869433A4 Q38254552-9C53483C-2D71-4CEC-BEF1-4E91742FA1D3 Q38268356-743D76B8-210B-42B7-BAD8-75B5209E2893 Q38271026-B9B73590-78C2-4CDE-9195-A9B8F39B2A9C Q38416938-29AB846B-1E16-4DA1-84B1-F29BB7A5CA43 Q38444909-7DA8250B-2AD4-412B-A6BF-143636B8773C Q38771731-5C40A131-A45F-4EB6-AFCF-61AF697F6C96 Q38790389-A7E5A43C-C918-41E1-B25E-29C688CDEF2A Q38790542-013C425E-7835-41CF-A635-4784DE6D09C3 Q38819031-DC9CAF23-BF05-4576-9B0F-BB653562BE56 Q38828102-305D36A9-2B05-40A9-954F-709BE6BA3947 Q38894994-63D3973A-26C9-4133-8560-F9485208DAA2 Q39223917-ABCA8428-684B-4278-A002-E7317986F42C Q39332399-5BEF27F3-F306-46EB-9207-7D940D38A1AB Q39392472-36D4A1F0-8112-4F17-BEA0-E00C65A52648 Q39741408-5AB8443B-71D7-48B3-BC04-8E4EC5D521BA Q39815208-25E9610B-3609-4492-B0F8-180C21049712 Q40440471-47142878-EACB-45A6-A335-41C0FEB243E3

P2860

Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation.

http://www.wikidata.org/entity/Q38435600

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation.

@en

type

label

Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation.

@en

prefLabel

Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation.

@en

P1433

Q38435600-080E9EB7-E608-478A-BE27-4FE1DFA772B1

P1476

Q38435600-0709BA8F-27CD-4410-B7F6-607F40FFDC64

P2093

Q38435600-183000C8-52D2-425B-B1D7-693C4E1A6187

Q38435600-3D71D820-5940-4E65-A9BA-D82980BE2F07

Q38435600-7FD51500-42AF-48A3-87E4-AF6D76977CEF

Q38435600-8956C9F7-FDDC-46E9-9475-A8B1ABCBFB8F

Q38435600-958FFEBA-A1D8-4458-A733-D20821C88963

Q38435600-9F2809A2-2457-4E72-B294-FC574609423B

Q38435600-A441E8E8-1B4D-4CF3-901D-E0A6F1B7294C

P2860

Q38435600-0256E717-39DC-403C-99E5-4DB297E5A5F6

Q38435600-0CA3A9A3-7DB3-4310-9EFB-82F45A157C99

Q38435600-108D079F-936C-43CF-9340-F17DF09DB1F4

Q38435600-25D45046-E5C3-48F6-9389-55D35F64EFF6

Q38435600-295CC733-D0EF-4B5F-A3D8-7728DDA7518A

Q38435600-369D8DF4-9828-4946-A863-DF58BF524982

Q38435600-44C21E58-EC72-44DE-9FF7-EAC8F74B1C54

Q38435600-548F415E-D145-4AA0-880B-FCA3E856DB25

Q38435600-5DCED898-9F2B-4F80-A2C0-FE9BCAA759AA

Q38435600-70DA58D9-B81B-4D98-8EF9-63B2449D8AAB

P304

Q38435600-65DB7235-884C-4209-B99C-6147803F8BBE

P31

Q38435600-CF837F6F-E129-419C-9008-78CF9C0D23BE

P356

Q38435600-F68163A9-2B51-4963-BFFE-4F365874117B

P407

Q38435600-19761559-7641-4C8D-948D-401570437878

P433

Q38435600-463A213D-B94C-42A4-AF01-3B1DE480FCD6

P478

Q38435600-79A5DE4A-7EB2-44DA-820F-16DBFFFFD223

P50

Q38435600-B7B6B631-D235-4225-A41E-F85512E6EDDA

P577

Q38435600-B5C74F50-9F0C-41A4-A507-9A30F400E08B

P698

Q38435600-EC9A659B-ECBA-4660-87A8-E3011DF0D27C

P921

Q38435600-86BC81C5-9B53-4998-9427-90770C0D8359

P932

Q38435600-C87C5841-1DD6-4DCD-A572-2E77806C9545

P356

CIRCULATIONAHA.111.053272

P1433

P1476

Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation

@en

P2093

Ayano Takeuchi

http://www.w3.org/2001/XMLSchema#string

David S Rosenbaum

http://www.w3.org/2001/XMLSchema#string

Ian D Greener

http://www.w3.org/2001/XMLSchema#string

J Emanuel Finet

http://www.w3.org/2001/XMLSchema#string

J Kevin Donahue

http://www.w3.org/2001/XMLSchema#string

Maria Strom

http://www.w3.org/2001/XMLSchema#string

Tomonori Igarashi

http://www.w3.org/2001/XMLSchema#string

P2860

Basic Mechanisms of Cardiac Impulse Propagation and Associated Arrhythmias

Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation

Paradigm of genetic mosaicism and lone atrial fibrillation: physiological characterization of a connexin 43-deletion mutant identified from atrial tissue

Connexin40 imparts conduction heterogeneity to atrial tissue

Cardiac conduction abnormalities in mice lacking the gap junction protein connexin40

Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat.

Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation.

Altered pattern of connexin40 distribution in persistent atrial fibrillation in the goat.

Selective molecular potassium channel blockade prevents atrial fibrillation

Therapeutic implications of atrial fibrillation mechanisms: can mechanistic insights be used to improve AF management?

P304

216-225

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.111.053272

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

Yoshihisa Fujino

P577

2011-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22158756

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation

P932

3260348

http://www.w3.org/2001/XMLSchema#string